Steven
@AIwithSteven
Founder @ http://NexTrial.ai | Elevating people, not replacing them | Clinical Trials, Pharma, AI & Transformation | 🚴 Gravel + Global | Speaker
AI shouldn’t replace people. It should elevate them. From Biogen → Takeda → NuBank → ADM → NexTrial.ai, my throughline has been clear: The future isn’t automated. It’s augmented. My first Substack is live: 👉 steventhompsonai.substack.com/p/elevating-pe… #AI…
Equity isn’t about caring harder. It’s about building systems that make fairness the default. That’s the opportunity in clinical research: Fix the rules → access expands. Fix the workflows → trust grows. Fix the documentation → more people qualify. Fix the structure → the…
Equity isn’t a belief. It’s the structure underneath. Fix the system → the outcomes change. #ClinicalResearch #HealthEquity #SystemsThinking #EthicsInAI
💉 The quiet signal this week is vaccines. Merck’s CAPVAXIVE and GSK’s Arexvy mark the shift from regulatory process to predictive readiness, where orchestration turns speed into access. Celina’s Predictive-to-Proof model connects activation to impact. 🔗 Read TrialForward…
Startups and cycling share the same metric: fatigue resistance. Everyone looks strong at kilometer 10. The difference shows at 250. In AI, it’s not who launches first. It’s who slows down the least when complexity hits. Efficiency > acceleration. #AI #Startups #Leadership…
In machine learning, "pruning" removes low-signal weights to make models faster. In clinical trials, we just discovered the same principle applies to operations. Equipment lists. Feasibility forecasts. SOP templates. They're all operational priors that drift while reality…
The AI arms race isn't about better models. It's about who understands what AI should never do. New essay on why the prediction-judgment divide is the only moat that matters: open.substack.com/pub/steventhom… #AI
🚀 Patent milestone: NexTrial.ai has filed for USPTO protection on our Agentic AI Clinical Trial Platform. Our moat? 🔹 Zero-rejection trial activation 🔹 Predictive patient retention 🔹 Immutable attribution trails 🔹 Dynamic global compliance This isn’t trial…
The clinical AI arms race everyone's missing While biotech leaders debate "which AI vendor has the best algorithm," the real battle is happening at the systems level. I analyzed the competitive landscape and found a clear split: 🏆 Winners: Building AI that orchestrates across…
Live today 12:00 ET. Not trial tech. Trial orchestration. Celina, our AI co-pilot, cuts activation from 120 days to 30. Audit-ready FDA 🇺🇸, ANVISA 🇧🇷, CDSCO 🇮🇳. 👉 Register: linkedin.com/events/agentic… #ClinicalTrials #AI #HealthTech #Compliance
Delete the maze. Don’t digitize it. Activation-ready in 30 days, not 120. Audit-ready by design. Built FDA 🇺🇸 first, now expanding into ANVISA 🇧🇷 + CDSCO 🇮🇳. 👉 Register: linkedin.com/events/agentic… #ClinicalTrials #AI #HealthTech #ComplianceMatters
Only 1% of oncology trial participants are Hispanic. 67% of trials cluster in North America + Europe. This isn't a diversity problem. It's a regulatory translation crisis. How to design protocols for Delhi, not just Denver 👇open.substack.com/pub/steventhom… #DeleteTheMaze…
This Thursday, I’ll join Dr. Alex Lee to show how protocol-aware AI is changing clinical trial activation. ⏱️ 120 days → 30 days 🚫 Zero rejection, zero delay ✅ FDA, ANVISA, CDSCO audit-ready Register here: linkedin.com/events/agentic…
United States 趋势
- 1. LeBron 76.7K posts
- 2. #DWTS 52.6K posts
- 3. #LakeShow 3,717 posts
- 4. Whitney 15.8K posts
- 5. Keyonte George 1,827 posts
- 6. Reaves 7,889 posts
- 7. Peggy 17.8K posts
- 8. Celebrini 4,575 posts
- 9. Elaine 17.4K posts
- 10. Orioles 6,810 posts
- 11. Jazz 26.8K posts
- 12. Grayson 6,934 posts
- 13. #TheFutureIsTeal 1,491 posts
- 14. Taylor Ward 3,454 posts
- 15. Dylan 25K posts
- 16. #WWENXT 16.8K posts
- 17. Tatum 15.8K posts
- 18. Winthrop 2,479 posts
- 19. #Lakers 1,594 posts
- 20. Angels 31.9K posts
Something went wrong.
Something went wrong.